GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development – an ...
A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...
Researchers at Leipzig University have developed a new process for reversing the polarity of chemical compounds, also known ...
Researchers have determined how children's immune systems react to different kinds of cancer depending on their age. The study reveals significant differences between the immune response of children ...
T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...
TOM STANDAGE | THE ECONOMIST | IT SEEMS APPROPRIATE that 2025 ... Our “Wild cards” section offers a selection to watch out for, including a devastating solar storm, the discovery of lost ancient texts ...
You might just know someone, close or distant, who has struggled with drug addiction at one point in time. It could be a distant relative or someone you went to school with, but the sheer probability ...
Tom Holland sits in a striped silk armchair near the fireplace. He is wearing white On running shoes, wide-leg trousers, and an ivory sweatshirt that he quickly peels off, issuing a muffled ...
Her work previously appeared on ok.co.uk, in OK! Magazine and Reach PLC magazines. Tom Brady/Instagram Tom Brady welcomed in 2025 surrounded by his children. On Wednesday, Jan. 1, the NFL icon ...
Roche is wasting no time in getting out its checkbook in 2025, signing a new biobucks-heavy pact that aims to add another new antibody-drug conjugate (ADC) to its pipeline. Roche, which put ...
The market is projected to grow from $11B in 2024 to $40B by 2030, driven by both conventional bispecifics and advancements such as antibody-drug and ... Antibody Discovery process can align ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback